BioSpace News Archive

IMV Inc. today announced that it will hold a conference call and webcast on Friday, November 11, 2022, at 8:00 a.m. ET to discuss the company’s 2022 third quarter financial and operational results.

AVROBIO, Inc today reported financial results for the third quarter ended Sept. 30, 2022 and provided a business update.

AdaptHealth Corp. announced today financial results for the third quarter ended September 30, 2022.

Arbutus Biopharma Corporation today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 11:30 am GMT / 6:30 am EDT.

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today reported financial results for the third quarter ended September 30, 2022 and provided recent business updates.

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will present at two upcoming investor conferences.

Oncotelic Therapeutics, Inc today announced that it has submitted a clinical study protocol to the US Food and Drug Administration (“FDA”) for the initiation of a Phase 1 Trial (designated “G101") for OT-101, the Company’s transforming growth factor beta 2 (“TGF-β2”) inhibitor, as a treatment for patients with recurrent/relapsed DMG.

Ocugen, Inc. today reported financial results for the quarter ended September 30, 2022, and provided a general business update.

Trevi Therapeutics, Inc. today announced that Jennifer Good, President and Chief Executive Officer, and Lisa Delfini, Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, at 3:35 p.m. ET.

Korro Bio, Inc today announced the appointment of Venkat Krishnamurthy, Ph.D., as Senior Vice President, Head of Platform and Stephanie Engels as Senior Vice President, Head of People and Culture.